Indy startup has rare disease in its sights
Founders of Chondrial Therapeutics believe that if further testing validates their treatment for Friedreich’s ataxia, it could be a blockbuster with annual sales topping $1 billion.
Founders of Chondrial Therapeutics believe that if further testing validates their treatment for Friedreich’s ataxia, it could be a blockbuster with annual sales topping $1 billion.
Gov. Mike Pence thinks his HIP 2.0 plan would reform Medicaid in line with conservative principles. To the extent the Obama administration agrees, that’s the biggest hurdle to get the plan approved.
An affiliate of Lutheran Health Network in northeast Indiana that concentrates on health-related businesses services expects to nearly triple its workforce.
Of the insurer’s $9.3 million in profit in the second quarter, only $4.1 million was attributed to its core operations.
Two insurers announced Tuesday that they are partnering for an ambitious project to establish one of the nation's largest health-information exchanges, an effort they hope will reduce duplication and improve patient outcomes.
State officials met Tuesday with members of the Pokagon Band of Potawatomi Indians in an effort to satisfy federal regulators who are considering a proposed expansion of the state’s low-income health insurance program.
The Indiana Coalition Against Sexual Assault suspended its operations after failing to pay payroll and other taxes, raising alarm that victims will fall through the cracks.
WellPoint saw 218,000 members of its health plans disappear because their employers ended their group plans. Other insurers, however, say small employers are ending their plans more slowly than expected.
Investors seem to have rediscovered the Midwest this year, pouring a record $777 million into 139 companies, according to BioEnterprise. In the first half of 2013, Midwest companies raised $351 million.
The Food and Drug Administration said Friday it will permit Jardiance tablets to be used by adult patients with type 2 diabetes who also are trying to control their condition with diet and exercise.
The site of the former Wishard Memorial Hospital could become home to a new combined downtown hospital for Indiana University Health.
Indiana University Health fell off U.S. News’ honor roll of the nation’s top 1 percent of hospitals. Because of Obamacare and other trends, perhaps IU Health should be happy about that.
Gov. Mike Pence told U.S. Health and Human Services Secretary Sylvia Burwell that he wants to maintain Indiana's "freedom and flexibility" under any expansion of Medicaid.
Management failures by the Obama administration set the stage for the computer woes that paralyzed the president's new health care program last fall, nonpartisan investigators said in testimony released Wednesday.
WellPoint Inc.’s profit fell in the second quarter, but still topped Wall Street’s expectations. The health insurer raised its full-year profit forecast and projections for enrollment in its health plans.
Anthem told regulators that the 12.5-percent rate increase was needed because of higher costs for medical services, pharmaceuticals and fees levied by the federal government as part of the Affordable Care Act.
In a deal expected to “change college sports forever,” the NCAA agreed Tuesday to settle a class-action head injury lawsuit by creating a $70 million fund to diagnose thousands of current and former college athletes to determine if they suffered brain trauma.
CNO Financial Group Inc. earned $78.1 million compared with profit of $77.1 million in the same period of 2013.
The bipartisan agreement includes $10 billion in to make it easier for veterans who can’t get prompt appointments with Veterans Affairs doctors to obtain outside care; $5 billion to hire doctors, nurses and other medical staff; and about $1.5 billion to lease 27 new clinics across the country.
Results of a Roche clinical trial mirror those produced by an experimental Lilly drug two years ago. Lilly executives say that validates their approach in the multi-billion-dollar race to market the first drug to reverse Alzheimer’s.